[CRVS] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
17-Aug-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- -53.03%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -5,995 -46,672 -46,939 -55,663 -36,375 -31,335 -176 79.94%
Tax -1,172 -2,925 2,283 -842 -594 -35 0 -
NP -4,823 -43,747 -46,939 -55,663 -36,375 -31,335 -176 73.54%
Tax Rate - - - - - - - -
Total Cost 4,823 43,747 46,939 55,663 36,375 31,335 176 73.54%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -0.16 -1.49 -1.71 -2.72 -2.36 -1.54 -1.03 -26.66%
EPS Diluted -0.16 -1.49 -1.71 -2.72 -2.36 -1.54 -1.03 -26.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.